| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:Quinpirole
CAS:80373-22-4
Package:100mg/RMB 17500;25mg/RMB 10600;50mg/RMB 13800
|
Quinpirole manufacturers
- Quinpirole
-
- $2500.00
-
2026-04-21
- CAS:80373-22-4
- Purity:
- Supply Ability: 10g
|
| | Quinpirole Basic information |
| Product Name: | Quinpirole | | Synonyms: | (4aR,8aR)-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H-pyrazolo[3,4-g]quinoline;LY-156258;1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-5-propyl-, (4aR,8aR)- | | CAS: | 80373-22-4 | | MF: | C13H21N3 | | MW: | 219.33 | | EINECS: | | | Product Categories: | | | Mol File: | 80373-22-4.mol |  |
| | Quinpirole Chemical Properties |
| Boiling point | 383.9±30.0 °C(Predicted) | | density | 1.070±0.06 g/cm3(Predicted) | | pka | 15.40±0.20(Predicted) |
| | Quinpirole Usage And Synthesis |
| Uses | Quinpirole (LY 171555) is a dopamine D2/D3 receptor agonist with activity in reducing hypothalamic norepinephrine concentrations. The effects of Quinpirole are not produced by the selective D1 agonist SKF 38393 or the dextrorotatory isomer of Quinpirole, which lacks D2 agonist activity. By activating D2 receptors, Quinpirole leads to a decrease in dopamine metabolites, a decrease in hypothalamic norepinephrine concentrations, and a possible increase in MHPG sulfate by enhancing norepinephrine release[1]. | | Definition | ChEBI: A pyrazoloquinoline that is (4aR,8aR)-4,4a,5,6,7,8,8a,9-octahydro-1H-pyrazolo[3,4-g]quinoline substituted by a propyl group at position 5. It acts as a dopamine agonist. | | References | [1] Decrease in hypothalamic epinephrine concentration and other neurochemical changes produced by quinpirole, a dopamine agonist, in rats |
| | Quinpirole Preparation Products And Raw materials |
|